Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung Cancer

PORT is not independently associated with decreased LR or improved DFS/LCSD in this patient population. Given that the predominant failure pattern was distant recurrence, future clinical trials should focus on adjuvant systemic therapies, which may decrease distant recurrences in ypN2 patients.